-
'Psyched': Ketamine Spray Approved, MindMed Explores Europe, John Hopkins Begins 'Real-World' Study
Friday, August 14, 2020 - 12:51pm | 851FDA Expands Psychiatric Indications For Nasal Spray Ketamine Last week, the FDA approved suicidal tendencies as additional qualifying symptoms for the application of Spravato, a ketamine nasal spray used in psychiatric treatment. Spravato is the brand name for esketamine, a chemical sibling of...